{
  "symbol": "GPN",
  "year": 2024,
  "Period": "Q3",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": -0.2732,
    "outlook_sentiment": 0.2498,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.141
  },
  "top_positive": [
    {
      "sent": "ITEM 2 \u2014 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS (c) Purchases of Equity Securities by the Issuer and Affiliated Purchasers Information about the shares of our common stock that we repurchased during the quarter ended March\u00a031, 2024 is set forth below: Period Total Number of Shares Purchased (1) Approximate Average Price Paid per Share, excluding commission Total Number of Shares Purchased as Part of Publicly Announced Plans or Progra\ns outstanding and capital expenditures; statements we make regarding guidance and projected financial results for the year 2024; the effects of general economic conditions on our business; statements about the benefits of our acquisitions or divestitures, including future financial and operating results and the completion and expected timing of our acquisitions or completion of anticipated benefits or strategic initiatives; our success and timing in developing and introducing new services and expanding our business; and other statements regarding our future financial performance and the company's plans, objectives, expectations and intentions.",
      "score": 0.9762
    },
    {
      "sent": "The following table sets forth the computation of diluted weighted-average number of shares outstanding for the three months ended March\u00a031, 2024 and 2023: Three Months Ended March 31, 2024 March 31, 2023 (in thousands) Basic weighted-average number of shares outstanding 256,926 263,115 Plus: Dilutive effect of stock options and other share-based awards 662 \u2014 Diluted weighted-average number of shares outstanding 257,588 263,115 NOTE 13\u2014 SUPPLEMENTAL BALANCE SHEET INFORMATION Cash, cash equivalents and restricted cash Cash and cash equivalents include cash on hand and all liquid investments with a maturity of three months or less when purchased.",
      "score": 0.9723
    },
    {
      "sent": "The following table sets forth the computation of diluted weighted-average number of shares outstanding for the three months ended March\u00a031, 2024 and 2023: Three Months Ended March 31, 2024 March 31, 2023 (in thousands) Basic weighted-average number of shares outstanding 256,926 263,115 Plus: Dilutive effect of stock options and other share-based awards 662 \u2014 Diluted weighted-average number of shares outstanding 257,588 263,115 NOTE 13\u2014 SUPPLEMENTAL BALANCE SHEET INFORMATION Cash, cash equivalents and restricted cash Cash and cash equivalents include cash on hand and all liquid investments with a maturity of three months or less when purchased.",
      "score": 0.9723
    }
  ],
  "top_negative": [
    {
      "sent": "Although we have not experienced significant exposure or adverse effects on our business and financial results to date, the extent to which these events could affect the global economy and our operations is difficult to predict at this time.",
      "score": -0.68
    },
    {
      "sent": "The following table includes estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied or partially unsatisfied at March\u00a031, 2024.",
      "score": -0.6597
    },
    {
      "sent": "ITEM 3\u2014QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK For a discussion of our exposure to market risk,\u00a0refer\u00a0to Part II, Item 7A, \"Quantitative and Qualitative Disclosures About Market Risk,\" contained in our Annual Report on Form 10-K for the year ended December\u00a031, 2023.",
      "score": -0.6037
    }
  ],
  "forward_snippets": [
    "We are evaluating how the enhanced disclosure requirements of ASU 2023-09 will affect our presentation, and we will include the incremental disclosures upon the effective date.",
    "We are evaluating how the enhanced disclosure requirements of ASU 2023-07 will affect our presentation, and we will include the incremental disclosures upon the effective date.",
    "We expect that approximately $ 1.2 billion of the goodwill from this acquisition will be deductible for income tax purposes.",
    "We are evaluating how the enhanced disclosure requirements of ASU 2023-07 will affect our presentation, and we will include the incremental disclosures upon the effective date.",
    "We expect that approximately $ 1.2 billion of the goodwill from this acquisition will be deductible for income tax purposes."
  ],
  "curated_text": "Symbol: GPN. Year: 2024. Period: Q3. ReportType: Q10. Section: Management Discussion and Analysis (MD&A). Key metrics include sentiment, forward outlook, and risk hedging.  Top positive sentences: ITEM 2 \u2014 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS (c) Purchases of Equity Securities by the Issuer and Affiliated Purchasers Information about the shares of our common stock that we repurchased during the quarter ended March\u00a031, 2024 is set forth below: Period Total Number of Shares Purchased (1) Approximate Average Price Paid per Share, excluding commission Total Number of Shares Purchased as Part of Publicly Announced Plans or Progra\ns outstanding and capital expenditures; statements we make regarding guidance and projected financial results for the year 2024; the effects of general economic conditions on our business; statements about the benefits of our acquisitions or divestitures, including future financial and operating results and the completion and expected timing of our acquisitions or completion of anticipated benefits or strategic initiatives; our success and timing in developing and introducing new services and expanding our business; and other statements regarding our future financial performance and the company's plans, objectives, expectations and intentions. The following table sets forth the computation of diluted weighted-average number of shares outstanding for the three months ended March\u00a031, 2024 and 2023: Three Months Ended March 31, 2024 March 31, 2023 (in thousands) Basic weighted-average number of shares outstanding 256,926 263,115 Plus: Dilutive effect of stock options and other share-based awards 662 \u2014 Diluted weighted-average number of shares outstanding 257,588 263,115 NOTE 13\u2014 SUPPLEMENTAL BALANCE SHEET INFORMATION Cash, cash equivalents and restricted cash Cash and cash equivalents include cash on hand and all liquid investments with a maturity of three months or less when purchased. The following table sets forth the computation of diluted weighted-average number of shares outstanding for the three months ended March\u00a031, 2024 and 2023: Three Months Ended March 31, 2024 March 31, 2023 (in thousands) Basic weighted-average number of shares outstanding 256,926 263,115 Plus: Dilutive effect of stock options and other share-based awards 662 \u2014 Diluted weighted-average number of shares outstanding 257,588 263,115 NOTE 13\u2014 SUPPLEMENTAL BALANCE SHEET INFORMATION Cash, cash equivalents and restricted cash Cash and cash equivalents include cash on hand and all liquid investments with a maturity of three months or less when purchased. Top negative sentences: Although we have not experienced significant exposure or adverse effects on our business and financial results to date, the extent to which these events could affect the global economy and our operations is difficult to predict at this time. The following table includes estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied or partially unsatisfied at March\u00a031, 2024. ITEM 3\u2014QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK For a discussion of our exposure to market risk,\u00a0refer\u00a0to Part II, Item 7A, \"Quantitative and Qualitative Disclosures About Market Risk,\" contained in our Annual Report on Form 10-K for the year ended December\u00a031, 2023. Forward-looking snippets: We are evaluating how the enhanced disclosure requirements of ASU 2023-09 will affect our presentation, and we will include the incremental disclosures upon the effective date. We are evaluating how the enhanced disclosure requirements of ASU 2023-07 will affect our presentation, and we will include the incremental disclosures upon the effective date. We expect that approximately $ 1.2 billion of the goodwill from this acquisition will be deductible for income tax purposes. We are evaluating how the enhanced disclosure requirements of ASU 2023-07 will affect our presentation, and we will include the incremental disclosures upon the effective date. We expect that approximately $ 1.2 billion of the goodwill from this acquisition will be deductible for income tax purposes."
}